SRTA Stock Analysis: Buy, Sell, or Hold?
SRTA - Strata Critical Medical, Inc. Class A Common Stock
$5.47
0.04 (0.74%)
▲
5d:
+2.43%
30d:
+21.83%
90d:
+24.32%
BUY
MODERATE Confidence
Analysis Updated: May 14, 2026 12:00 AM ET
Earnings: May 12, 2026
0d
Smart Money Accumulation
SRTA is down 5.1% this week, but smart money is accumulating calls. Top strike: $5 2026-06-18 with 11 OI. Call ratio: 100% View Scanner →
Strength: 7.6/10
Get Alerted When SRTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: SRTA shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
💡 BUY OPPORTUNITY: SRTA shows positive signals but monitor for confirmation. Market pricing in 0% annual growth which appears achievable. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: SRTA is currently trading at $5.47, which is considered extended relative to its 30-day fair value range of $4.32 to $5.31. From a valuation perspective, the stock is trading at a discount (Forward PE: -547.0) compared to its historical average (61.6). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.
Technical Outlook: Technically, SRTA is in a downtrend. Immediate support is located at $4.80, while resistance sits at $5.82.
Market Sentiment: SRTA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.88 (+62.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SRTA is in a downtrend. Immediate support is located at $4.80, while resistance sits at $5.82.
Market Sentiment: SRTA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.88 (+62.2%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.32 -
$5.31
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
66.7%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 62.2% below Wall St target ($8.88)
- BULLISH: Market expects only 0% annual growth - appears undervalued
Trading Range Analysis
30-Day Trading Range
$4.32 -
$5.31
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.80
Resistance Level
$5.82
Current Trend
Downtrend
Technical data as of
May 14, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-547.00
Wall Street Target
$8.88
(+62.2%)
Revenue Growth (YoY)
87.4%
Profit Margin
20.6%
PE vs Historical
-547.0 vs 61.6
CHEAP
Share & Embed Analysis
Last updated: May 14, 2026 7:44 PM ET
Data refreshes hourly during market hours. Next update: 8:44 PM
Data refreshes hourly during market hours. Next update: 8:44 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SRTA showing a specific setup today?
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$513 | 66 BUY |
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$246 | 59 HOLD |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$141 | 62 BUY |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$21 | 63 BUY |
|
CON
Concentra Group Holdings… |
STRONG BUY
8 analysts |
$30 | 62 BUY |